Christopher S. Hackett

Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC

Fredrik J. Swartling, Vasil Savov, Anders I. Persson et al. · Cancer Cell · 2012 · 211 citations · Full text

Medicine, Cancer Biology, Oncology +12

miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma

Alexander Swarbrick, Susan L. Woods, Alexander Shaw et al. · Nature Medicine · 2010 · 202 citations · Full text

Life Sciences, Genetics, Oncology +17

A Dual Phosphoinositide-3-Kinase α/mTOR Inhibitor Cooperates with Blockade of Epidermal Growth Factor Receptor in <i>PTEN</i> -Mutant Glioma

Qi-Wen Fan, Christine Cheng, Theodore Nicolaides et al. · Cancer Research · 2007 · 194 citations · Full text

Medicine, Oncology, Pharmacology +16

Genetic determinants of malignancy in a mouse model for oligodendroglioma.

William A. Weiss, Michael J. Burns, Christopher S. Hackett et al. · PubMed · 2003 · 175 citations

Medicine, Genetics, Oncology +17

Pleiotropic role for<i>MYCN</i>in medulloblastoma

Fredrik J. Swartling, Matthew Grimmer, Christopher S. Hackett et al. · Genes & Development · 2010 · 174 citations · Full text

Medicine, Oncology, Pathology +17